Investors
IR News
Strategy
Analysts
Corporate Governance
Shareholder FAQs
Annual Report
Alerts Service
Latest Presentations
Webcast
Investors
/ IR News
Search for:
Type:
Any Topic
Directors Shareholding
Holdings in Company
Results
Board Changes
Regulatory
Clinical Trials
Other
From:
All
2010
2009
2008
2007
2006
2005
2004
2003
2002
INVESTOR RELATIONS NEWS
14 July 2010
Interim Management Statement
05 July 2010
Appointment of Joint Brokers
15 June 2010
Holding(s) in Company
01 June 2010
Non-Executive Director Share Purchase
24 May 2010
Executive Director Share Purchase
04 May 2010
Holding(s) in Company
28 April 2010
Notice of Results
30 March 2010
Exercise of Options
29 March 2010
EU Phase III trial for Juvista is fully recruited
24 March 2010
Holding(s) in Company
Results Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
>>
PRODUCT PIPELINE
Juvista - Scar Reduction in skin
Adaprev – Scar reduction in tendons
Prevascar - Reduced Scarring
Juvidex - Improved skin appearance
RN1005 - for reduction of scarring
SHARE PRICE
Data supplied by AXL Performance Solutions - http://www.axl.co.uk
ABOUT US
|
PRODUCTS
|
RESEARCH & DEVELOPMENT
|
PARTNERS
|
MEDIA
|
INVESTORS
|
CAREERS
|
VOLUNTEERS
privacy policy
